Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
Rigorous nationwide population-based cohort study with large sample, long follow-up, and multivariable adjustment demonstrates clear associations between thyroidectomy/thyroid hormone therapy and multiple metabolic outcomes; not practice-changing because it establishes risk rather than testing an intervention to mitigate it.
A single-centre retrospective study with modest sample size identifying predictive biomarkers for radioiodine response using immunohistochemistry and mutation analysis; results are encouraging but require validation in an independent cohort before clinical adoption.
This is a narrative review synthesizing experimental animal studies and emerging translational work on 3,5-T2; it raises mechanistic questions and identifies knowledge gaps rather than reporting a definitive clinical result or trial outcome.
A narrative review synthesizing mechanistic, epidemiological, and therapeutic evidence to recommend integration of liver assessment into cardiovascular-kidney-metabolic risk stratification and therapy selection in clinical practice.
Single-centre retrospective cohort study with clinical endpoints (PFS, OS) in a defined population, showing statistically significant associations, but limited by retrospective design, lack of mechanistic validation, and absence of external validation.
Population-based cluster analysis identifying three gout phenotypes, but no intervention comparison, no control group, and outcomes are observational descriptors of care patterns rather than clinical trial endpoints.
A comprehensive narrative review synthesizing current understanding of pediatric hyperuricemia genetics, mechanisms, and clinical management, intended to inform clinical practice and identify evidence gaps rather than report original research findings.
Retrospective integration of longitudinal biomarkers, dual-modal imaging, and genomics in a single-centre cohort identifies genotype-phenotype associations in RAIR-DTC, but lacks prospective validation or a randomized comparator to establish clinical utility.